Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort ascending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort ascending Functional Area Erscheinungsdatum
RWE Scientific data analyst II Hyderabad (Office) Indien Operations CTS Data and Digital Aug 06, 2024
Senior RWE Scientific Data Analyst Hyderabad (Office) Indien Operations CTS Data and Digital Aug 06, 2024
Senior Platform Linux Engineer / DevOps Prague Tschechische Republik Operations CTS Technology Transformation Aug 06, 2024
BS/Sol.Delivery-Data Engineer Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
ITOT Specialist Indianapolis USA Operations CTS Technical Operations Aug 08, 2024
Associate Director, M365 Platform Design & Delivery Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 12, 2024
Real World Evidence Research Analyst Dublin (Novartis Corporate Center (NOCC)) Irland Operations CTS Market Access Aug 12, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit und Finanzen Aug 12, 2024
Assoc. Director, Technical Solution Delivery, Global Clinical Operations Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Global Clinical Operations Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Global Clinical Supply Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Assoc. Director, Business Analyst, Technical Research & Development (TRD) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Snr. Specialist, IT Business Analyst - Regulatory Affairs Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Director- Enterprise Architect(Architecture Design/Cross functional - SAP Implementation) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Gbl Procurement Head IT Infra & Security Barcelona Gran Vía Spanien People & Organization CTS Beschaffung Aug 27, 2024
Senior Developer, Generative AI Navigator (Python) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 27, 2024
Sr. Spec. DDIT IES Database Services INSURGENTES Mexiko Operations CTS Technology Transformation Aug 27, 2024
Snr. Specialist MDM (Master Data Management - implementation using Reltio) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Snr Specialist(Power BI & Embedded Analytics - Web applications) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Salesforce Marketing Cloud Architect( MCP OR MCI , Data Cloud) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Senior Analyst - Competitive Social Intelligence Hyderabad (Office) Indien Operations CTS Marketing Aug 30, 2024
Associate Director(SAP SD S/4Hana) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Director - Enterprise Architect, APD Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. Platform Analytics Architecture Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Senior Manager Hyderabad (Office) Indien Operations CTS Marketing Sep 03, 2024
Snr Specialist, IT Business Analyst, Technical Design (Regulatory Affairs) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 13, 2024
Patient Engagement Lead İstanbul Kavacık Türkei Corporate Affairs CTS Communications & Public Affairs Sep 03, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Humanressourcen Aug 19, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit und Finanzen Aug 19, 2024
Associate Director for Information Security and Compliance, M&A Team Prague Tschechische Republik Operations CTS Technology Transformation Aug 20, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexiko Finance CTS Audit und Finanzen Aug 20, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 21, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit und Finanzen Aug 22, 2024
Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Manager - Field Effectiveness Hyderabad (Office) Indien Operations CTS Marketing Sep 03, 2024
Buyer with German Prague Tschechische Republik Operations CTS Beschaffung Aug 23, 2024
Associate Director, Veeva CRM Architect Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 03, 2024
Principal Scientific Writer Hyderabad (Office) Indien Operations CTS Research & Development Sep 03, 2024
Manager - Advanced Analytics Hyderabad (Office) Indien Operations CTS Data and Digital Mai 17, 2024
Microsoft 365 Solution Architect Prague Tschechische Republik Operations CTS Technology Transformation Mai 16, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Humanressourcen Mai 19, 2024
Analyst – Patient Oriented Programs Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Associate Director Data Science Hyderabad (Office) Indien Operations CTS Data and Digital Mai 20, 2024
Sr. Spec. DDIT ISC IES Hyderabad (Office) Indien Operations CTS Technology Transformation Mai 21, 2024
Senior Analyst - Data & Products Hyderabad (Office) Indien Operations CTS Marketing Mai 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.